Eric Topol, MD, is the founder and director of the Scripps Research Translational Institute, professor of molecular medicine, and executive vice president of Scripps Research. As a researcher, he has published over 1,200 peer-reviewed articles, with more than 280,000 citations, elected to the National Academy of Medicine, and is one of the top ten most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.
In 2016, Topol was awarded a $207 million grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling 1 million participants in the U.S. This is in addition to his role as principal investigator for a flagship $35 million NIH grant to promote innovation in medicine. He was the founder of a new medical school at Cleveland Clinic, Lerner College of Medicine, with Case Western University. He has over 300,000 followers on Twitter (@EricTopol) where recently he has been reporting insights and research findings for COVID-19. Besides editing several textbooks, he has published three bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service's integration of AI and new technologies.
© 2024 by the President and Fellows of Harvard College